Moleculin Biotech (NASDAQ:MBRX) files for offering of common stock and warrants, size not disclosed. SEC Filing

More on Moleculin Biotech

Moleculin Biotech, Inc. (MBRX) Q3 2024 Earnings Call Transcript Moleculin accelerates data readout for its late-stage leukemia treatment to H2 2025 Seeking Alpha's Quant Rating on Moleculin Biotech Historical earnings data for Moleculin Biotech Financial information for Moleculin Biotech